Aveanna Healthcare Q2 Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion

Reuters
08/07
Aveanna Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion

Aveanna Healthcare Holdings Inc. announced its financial results for the second quarter, reporting a significant increase in both revenue and net income compared to the same period last year. The company achieved a second-quarter revenue of $589.6 million, marking a 16.8% increase over the prior year period. Net income for the quarter surged to $27.0 million, representing a substantial 94.3% rise from the previous year. The company's Adjusted EBITDA for Q2 2025 reached $88.4 million, a 93.6% increase from the prior year period. Aveanna has also updated its full-year 2025 financial outlook, raising its revenue guidance to greater than $2.3 billion, up from the previous estimate of greater than $2.15 billion. The full-year 2025 Adjusted EBITDA guidance has been increased to greater than $270 million, revised from more than $207 million. The company highlighted its acquisition of Thrive Skilled Pediatric Care as a strategic move to enhance its market presence and expand its core services. Aveanna continues to focus on providing high-quality home care for medically complex, high-cost patient populations, delivering significant value to its payor and government partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9507576-en) on August 07, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10